Press Enter for full results
, functional medicine researcher, data analyst, peptide specialist

, functional medicine researcher, data analyst, peptide specialist , functional medicine researcher, data analyst, peptide specialist

Marcus Reid is a functional medicine researcher, data analyst, and peptide specialist, and one of the people who built MyPeptidePal. The platform exists in part because of the years he spent immersed in clinical literature, real-world protocols, and the kind of hands-on experimentation that most textbooks skip entirely. He is not a physician and does not pretend to be. What he is, is someone who has done the work to understand how these compounds actually function at a biological level, what the research actually says versus what the forums claim, and how to explain it in a way that makes sense to anyone willing to learn. At MPP, Marcus contributed to building the knowledge base, the protocol frameworks, and the research systems that power the platform. His work covers tissue repair, metabolic health, hormonal optimization, longevity, cognitive function, and cosmetic applications. When the science gets complicated, his job is to make it click.

Articles by , functional medicine researcher, data analyst, peptide specialist

Tesamorelin + Ipamorelin Protocol: How to Cycle It, Timing & What to Expect

A tesamorelin and ipamorelin protocol typically runs 8 to 12 weeks on a 5-days-on, 2-days-off weekly schedule, dosed once nightly 30 to 90 minutes before sleep to align with the body's natural nocturnal growth hormone pulse. The cycle follows a graduated two-phase structure: an acclimation phase for the first four weeks at a lower combined dose, stepping up to a target maintenance dose for the remainder, followed by a break of four to eight weeks before restarting. This guide covers the full cycle structure, timing and frequency principles, what to expect week by week, and the common mistakes people make, while leaving the personalized dose, schedule, and cycle length to the MyPeptidePal Protocol Creator.

Protocols By Compound 11 min read

TB-500 Frag Protocol: How to Cycle It, Timing & What to Expect

TB-500 Frag is the colloquial name for TB-500, a synthetic peptide replicating the active fragment of Thymosin Beta-4. A typical protocol runs in two phases: a loading phase of four to six weeks dosed twice weekly, followed by a maintenance phase at reduced frequency, then an off-cycle break of four to eight weeks before repeating. The exact dose depends on whether the goal is acute injury recovery or chronic tissue remodeling, the user's experience level, and the delivery route, and is built in the MyPeptidePal Protocol Creator rather than fixed for everyone.

Protocols By Compound 10 min read

SS-31 Protocol: How to Cycle It, Timing & What to Expect

An SS-31 protocol is typically structured as a cycle of eight to twelve weeks, dosed three times per week for general wellness goals or daily for more intensive therapeutic applications, with a brief titration window in the first one to two weeks , titration meaning you start at a lower dose and step up over that period before settling into the target dose. Because mitochondrial benefit from SS-31 appears to persist well beyond the treatment window, off-cycle breaks are optional rather than physiologically required, though many people build in a rest month for practical and precautionary reasons. This guide covers the full cycle structure, timing and frequency principles, what to expect week by week, and the common mistakes people make, while leaving the personalized dose, schedule, and exact cycle length to the MyPeptidePal Protocol Creator.

Protocols By Compound 11 min read

Survodutide Protocol: How to Cycle It, Timing & What to Expect

Survodutide is a once-weekly subcutaneous injection built around two consecutive phases: a gradual escalation phase lasting roughly 20 weeks, where the dose steps up at regular intervals to protect GI tolerability, followed by a continuous maintenance phase that extends well beyond that. There is no defined off-cycle break; treatment runs continuously for the full protocol duration, which in Phase 3 trials reaches 76 weeks. The dose is determined by goal, GI tolerance history, and individual escalation pace, and the personalized starting point and target are built in the MyPeptidePal Protocol Creator rather than set to a single number that fits everyone.

Protocols By Compound 10 min read

Sermorelin Protocol: How to Cycle It, Timing & What to Expect

A Sermorelin protocol typically runs three to six months, dosed once nightly via subcutaneous injection on a five-days-on, two-days-off weekly schedule. The cycle moves through a titration shape: starting at a conservative initiation level, stepping up over the first several weeks as the body adjusts, then holding steady at a working level through the rest of the active cycle. After a full cycle, most protocols include a one to three month off-cycle break before restarting. The exact dose is determined by your goal, your individual IGF-1 response, and clinical factors, and is built for you in the MyPeptidePal Protocol Creator rather than set as a fixed number here.

Protocols By Compound 11 min read

Semaglutide + Cagrilintide Protocol: How to Cycle It, Timing & What to Expect

A semaglutide + cagrilintide protocol runs as a single long arc: a 16-week titration phase where both compounds are gradually escalated in tandem, followed by a 52-week maintenance phase at the full dose, all administered as one subcutaneous injection per week. There is no planned off-cycle break in the clinical design; this combination is built for continuous long-term use, not a short peptide cycle with a rest period. The dose moves through five steps over the titration phase, increasing every four weeks, and the specific dose at each step is what the MyPeptidePal Protocol Creator builds for you based on your goals and history. This guide covers the full cycle structure, timing principles, what to expect week by week, and the common mistakes that derail the protocol before results arrive.

Protocols By Compound 11 min read

Selank Protocol: How to Cycle It, Timing & What to Expect

A Selank cycle typically runs two to four weeks at a once-daily frequency, followed by a break of equal length before the next run. The cycle has a clear shape: an initiation period in the first week or two at a conservative dose, then a steady maintenance phase for the remainder. No dramatic escalation, no difficult off-ramp. The actual dose depends on your goal, your delivery route, and your experience level, and is built for you in the MyPeptidePal Protocol Creator.

Protocols By Compound 9 min read

PT-141 Protocol: How to Cycle It, Timing & What to Expect

PT-141 (bremelanotide) is an on-demand compound, not a daily cycle peptide, so the protocol looks nothing like a BPC-157 or growth hormone stack. Most people start conservatively, assess the full response over several hours, and step up gradually across successive uses until they find their effective level. Clinical practice recommends spacing at least three to four days apart to protect receptor sensitivity, with a cap of eight doses per month. This guide explains how that on-demand structure works, how the dose is shaped by goal and delivery route, what to expect from each dose, and the mistakes that trip people up, while leaving the personalized dose and schedule to the MyPeptidePal Protocol Creator.

Protocols By Compound 11 min read

Prostamax Protocol: How to Cycle It, Timing & What to Expect

A Prostamax protocol typically runs as a 4 to 6 week daily course, sometimes extended to 8 to 12 weeks for a gradual titration approach, followed by a rest period before the next cycle. The cycle opens with a lower dose to assess tolerability, then steps up gradually toward a maintenance level, a titration-then-hold structure rather than a fixed loading-drop split. One of the more distinctive features of this compound is that meaningful benefits, especially improvements in urinary flow and prostate comfort, often continue to develop for 4 to 6 weeks after the course ends, which is why rest periods between cycles tend to be longer than with many other peptides. The exact dose depends on the goal and individual response and is built in the MyPeptidePal app.

Protocols By Compound 11 min read

PNC-27 Protocol: How to Cycle It, Timing & What to Expect

A PNC-27 protocol is built around gradual titration over an eight to twelve week cycle, dosed subcutaneously once daily. The cycle follows a titration-then-maintenance shape, beginning at the lower end of the range and stepping upward approximately every two weeks as tolerance is established, then settling into a steady maintenance level that fits the goal and individual response, followed by a rest period of several weeks before repeating. This guide explains how the cycle is structured, what shapes the dose, what timing and frequency principles apply, and what researchers and community members commonly report week by week.

Protocols By Compound 10 min read

Pinealon Protocol: How to Cycle It, Timing & What to Expect

A Pinealon protocol runs in short, intermittent cycles of 10 to 20 consecutive days, dosed once daily, with no formal loading or maintenance phases. Because Pinealon works through gene expression modulation rather than acute receptor activity, the most meaningful results typically emerge during the four-week post-cycle consolidation window after dosing stops. Standard practice is one to two cycles per year, separated by three to six months off. The exact dose depends on the user's goal, experience level, and delivery route, and is built in the MyPeptidePal Protocol Creator.

Protocols By Compound 10 min read

PE-22-28 Protocol: How to Cycle It, Timing & What to Expect

A PE-22-28 protocol typically runs 8 to 16 weeks, dosed once daily, with a conservative low-dose starting phase in the first two weeks before settling into a stable maintenance phase for the remainder of the cycle. Off-cycle breaks of around four weeks are standard after a full run, though some supervised protocols use it as ongoing maintenance depending on individual response. This guide covers how a PE-22-28 cycle is structured and phased, what determines the dose, timing principles, what to expect week by week, and where people most often go wrong, while leaving the personalized dose and exact cycle length to the MyPeptidePal Protocol Creator.

Protocols By Compound 11 min read

Pancragen Protocol: How to Cycle It, Timing & What to Expect

A Pancragen protocol runs differently from most peptides you have encountered: the active cycle is just 10 to 20 days, dosed once daily, followed by a rest period of two to three months before the next cycle. There is no loading phase and no dose escalation ramp. The compound works by triggering changes in pancreatic beta-cell function and gene expression that continue unfolding after you stop taking it, which is exactly why the long break is built into the design and not optional. This guide explains how the cycle is structured, what determines the dose, the timing principles that matter, and what to expect across a full protocol.

Protocols By Compound 10 min read

Oxytocin Protocol: How to Cycle It, Timing & What to Expect

An oxytocin protocol runs four to twelve weeks at a once or twice daily frequency, with the delivery route shaping the cycle more than almost any other factor. Unlike many peptides, oxytocin does not use a distinct loading phase; instead, the dose is gradually titrated upward across the early weeks until the effective range is found, then held steady for the remainder of the cycle. Intranasal delivery is preferred for social and emotional goals because it reaches the brain via the olfactory pathway, while subcutaneous injection suits systemic goals like gut health or healing support. Off-cycle breaks of one to two weeks are commonly recommended after each cycle as a precaution. Your exact dose, timing, and cycle length are personalized in the MyPeptidePal Protocol Creator.

Protocols By Compound 11 min read

Ovagen Protocol: How to Cycle It, Timing & What to Expect

An Ovagen protocol runs as a short, focused cycle rather than the long continuous timelines common with other peptides. Standard cycles last 10 to 20 days, dosed once daily, with a long break of two to six months between cycles and two to three cycles completed per year. The cycle has no distinct loading phase: the dose stays consistent from the first day to the last, and the entire short course is the therapeutic run. This guide explains how that cycle is structured, what determines the dose, what to expect across a full course, and the mistakes that derail results. The personalized dose is built in the MyPeptidePal app.

Protocols By Compound 10 min read